Median salary
$118,900
per year · annualized USD
Typical range
$104.8k – $137.3k
25th–75th percentile
Disclosing pay
48.8%
21 of 43 roles
Live roles
43
open right now
BioMedical AI Research Engineer
Software Test Engineer - Medical Device Integration (Bedford, MA)
Senior/Staff Ultrasound System Engineer – Medical Device (San Diego, CA)
Digital Signal Processing Ultrasound Engineer – Medical Device (San Diego, CA)
Sr Medical Device Engineer (Process Development, Sensor Focus)
Senior Medical Device Research and Development Engineer
Software Development Process Engineer / Specialist (Medical Device)
Senior Medical Device Compliance Engineer
| Company | Median | Roles |
|---|---|---|
Haemonetics
|
$104,832 | 4 |
Philips
|
$148,000 | 3 |
Blue Water Thinking
|
$106,250 | 2 |
Xaira Therapeutics
|
$261,000 | 1 |
| DE Dexcom | $141,050 | 1 |
Johnson & Johnson
|
$137,284 | 1 |
St Vincent's Health Australia
|
$134,549 | 1 |
Siemens Healthineers
|
$130,530 | 1 |
| Location | Median | Roles |
|---|---|---|
| San Francisco | $110,000 | 3 |
See every Biomedical Engineer role
Browse the live listings, or save this search and get alerted the moment a new one posts.
The median salary for Biomedical Engineer roles is $118,900 per year. Most pay falls between $104,832 (25th percentile) and $137,284 (75th percentile), with the broader 10th–90th percentile band running from $104,832 to $148,000.
These figures are computed live from 43 active Biomedical Engineer roles on JobsRadar, of which 21 (48.8%) publish a salary range. Pay is normalized to annualized USD so roles can be compared on equal terms; the highest-paying roles listed above show their original posted currency. Numbers refresh every few hours as new roles are posted and older ones close.
Employers currently hiring well-paid Biomedical Engineer roles include Xaira Therapeutics, Philips, Dexcom, Cresilon and Inc..
Salary transparency varies by employer and region, so the disclosing share above reflects only roles that publish pay — not every open position. Use it as a directional benchmark rather than an exact offer.